胰腺頸部Castleman病1例報道_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

陳永進 ,  劉凱

吉林大學第一醫院肝膽胰外科（長春 130021）;

Corresponding?author：

劉凱, Email: liuk@jlu.edu.cn

Keywords：

Castleman病; 胰腺; 診斷

DOI：

10.7507/1007-9424.202203068

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 陳永進, 劉凱. 胰腺頸部Castleman病1例報道. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2022, 29(11): 1514-1515. doi: 10.7507/1007-9424.202203068 Copy

1.	Anagnostou D, Harrison CV. Angiofollicular lymph node hyperplasia (Castleman). J Clin Pathol, 1972, 25(4): 306-311.
2.	Zhao S, Wan Y, Huang Z, et al. Imaging and clinical features of Castleman disease. Cancer Imaging, 2019, 19(1): 53. doi: 10.1186/s40644-019-0238-0.
3.	Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer, 1956, 9(4): 822-830.
4.	Munshi N, Mehra M, van de Velde H, et al. Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leuk Lymphoma, 2015, 56(5): 1252-1260.
5.	Dispenzieri A, Armitage JO, Loe MJ, et al. The clinical spectrum of Castleman’s disease. Am J Hematol, 2012, 87(11): 997-1002.
6.	Siegel MO, Ghafouri S, Ajmera R, et al. Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease. Int J Infect Dis, 2016, 48: 49-51.
7.	Musters A, Assaf A, Gerlag DM, et al. Discovery of innovative therapies for rare immune-mediated inflammatory diseases via off-label prescription of biologics: the case of IL-6 receptor blockade in Castleman’s disease. Front Immunol, 2015, 6: 625. doi: 10.3389/fimmu.2015.00625.
8.	Frizzera G. Castleman’s disease and related disorders. Semin Diagn Pathol, 1988, 5(4): 346-364.
9.	Talarico F, Negri L, Iusco D, et al. Unicentric Castleman’s disease in peripancreatic tissue: case report and review of the literature. G Chir, 2008, 29(4): 141-144.
10.	Stevens EA, Strowd RE, Mott RT, et al. Angiofollicular lymph node hyperplasia resembling a spinal nerve sheath tumor: a rare case of Castleman’s disease. Spine J, 2009, 9(9): e18-e22. doi: 10.1016/j.spinee.2009.04.011.
11.	Shah D, Darji P, Lodha S, et al. Unicentric Castleman’s disease of abdomen. J Radiol Case Rep, 2013, 7(3): 26-33.
12.	Bucher P, Chassot G, Zufferey G, et al. Surgical management of abdominal and retroperitoneal Castleman’s disease. World J Surg Oncol, 2005, 3: 33. doi: 10.1186/1477-7819-3-33.
13.	Jiang L, Zhao LY, Liu Y, et al. Castleman’s disease of the neck: report of 4 cases with unusual presentations. J Oral Maxillofac Surg, 2011, 69(4): 1094-1099.
14.	Ghosh A, Pradhan SV, Talwar OP. Castleman’s disease—hyaline vascular type—clinical, cytological and histological features with review of literature. Indian J Pathol Microbiol, 2010, 53(2): 244-247.
15.	Van Rhee F, Stone K, Szmania S, et al. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol, 2010, 8(7): 486-498.
16.	Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control, 2014, 21(4): 266-278.

1. Anagnostou D, Harrison CV. Angiofollicular lymph node hyperplasia (Castleman). J Clin Pathol, 1972, 25(4): 306-311.
2. Zhao S, Wan Y, Huang Z, et al. Imaging and clinical features of Castleman disease. Cancer Imaging, 2019, 19(1): 53. doi: 10.1186/s40644-019-0238-0.
3. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer, 1956, 9(4): 822-830.
4. Munshi N, Mehra M, van de Velde H, et al. Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leuk Lymphoma, 2015, 56(5): 1252-1260.
5. Dispenzieri A, Armitage JO, Loe MJ, et al. The clinical spectrum of Castleman’s disease. Am J Hematol, 2012, 87(11): 997-1002.
6. Siegel MO, Ghafouri S, Ajmera R, et al. Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease. Int J Infect Dis, 2016, 48: 49-51.
7. Musters A, Assaf A, Gerlag DM, et al. Discovery of innovative therapies for rare immune-mediated inflammatory diseases via off-label prescription of biologics: the case of IL-6 receptor blockade in Castleman’s disease. Front Immunol, 2015, 6: 625. doi: 10.3389/fimmu.2015.00625.
8. Frizzera G. Castleman’s disease and related disorders. Semin Diagn Pathol, 1988, 5(4): 346-364.
9. Talarico F, Negri L, Iusco D, et al. Unicentric Castleman’s disease in peripancreatic tissue: case report and review of the literature. G Chir, 2008, 29(4): 141-144.
10. Stevens EA, Strowd RE, Mott RT, et al. Angiofollicular lymph node hyperplasia resembling a spinal nerve sheath tumor: a rare case of Castleman’s disease. Spine J, 2009, 9(9): e18-e22. doi: 10.1016/j.spinee.2009.04.011.
11. Shah D, Darji P, Lodha S, et al. Unicentric Castleman’s disease of abdomen. J Radiol Case Rep, 2013, 7(3): 26-33.
12. Bucher P, Chassot G, Zufferey G, et al. Surgical management of abdominal and retroperitoneal Castleman’s disease. World J Surg Oncol, 2005, 3: 33. doi: 10.1186/1477-7819-3-33.
13. Jiang L, Zhao LY, Liu Y, et al. Castleman’s disease of the neck: report of 4 cases with unusual presentations. J Oral Maxillofac Surg, 2011, 69(4): 1094-1099.
14. Ghosh A, Pradhan SV, Talwar OP. Castleman’s disease—hyaline vascular type—clinical, cytological and histological features with review of literature. Indian J Pathol Microbiol, 2010, 53(2): 244-247.
15. Van Rhee F, Stone K, Szmania S, et al. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol, 2010, 8(7): 486-498.
16. Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control, 2014, 21(4): 266-278.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

胰腺頸部Castleman病1例報道

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content